133 related articles for article (PubMed ID: 9405959)
1. Antidepressant efficacy in the treatment of dysthymia.
Invernizzi G; Mauri MC; Waintraub L
Eur Neuropsychopharmacol; 1997 Oct; 7 Suppl 3():S329-36. PubMed ID: 9405959
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of antidepressants for dysthymia: a meta-analysis of placebo-controlled randomized trials.
Levkovitz Y; Tedeschini E; Papakostas GI
J Clin Psychiatry; 2011 Apr; 72(4):509-14. PubMed ID: 21527126
[TBL] [Abstract][Full Text] [Related]
3. Drugs versus placebo for dysthymia.
Lima MS; Moncrieff J
Cochrane Database Syst Rev; 2000; (4):CD001130. PubMed ID: 11034701
[TBL] [Abstract][Full Text] [Related]
4. A comparison of drugs versus placebo for the treatment of dysthymia.
Lima MS; Moncrieff J
Cochrane Database Syst Rev; 2000; (2):CD001130. PubMed ID: 10796749
[TBL] [Abstract][Full Text] [Related]
5. [Treatment of dysthymia].
Pöldinger W
Praxis (Bern 1994); 2000 Dec; 89(51-52):2183-8. PubMed ID: 11197300
[TBL] [Abstract][Full Text] [Related]
6. [Dysthymia: a chronic illness and its treatment].
Aschauer HN
Wien Med Wochenschr; 1999; 149(18):503-10. PubMed ID: 10637954
[TBL] [Abstract][Full Text] [Related]
7. Challenges in the treatment of dysthymia: a narrative review.
Mathias L; Quagliato LA; Carta MG; Nardi AE; Cheniaux E
Expert Rev Neurother; 2024 Jul; 24(7):633-642. PubMed ID: 38805342
[TBL] [Abstract][Full Text] [Related]
8. Antidepressant use in nonmajor depression: secondary analysis of a program to encourage active, rewarding lives for seniors (PEARLS), a randomized controlled trial in older adults from 2000 to 2003.
Lakey SL; Gray SL; Ciechanowski P; Schwartz S; Logerfo J
Am J Geriatr Pharmacother; 2008 Mar; 6(1):12-20. PubMed ID: 18396244
[TBL] [Abstract][Full Text] [Related]
9. Moclobemide and imipramine in chronic depression (dysthymia): an international double-blind, placebo-controlled trial. International Collaborative Study Group.
Versiani M; Amrein R; Stabl M
Int Clin Psychopharmacol; 1997 Jul; 12(4):183-93. PubMed ID: 9347378
[TBL] [Abstract][Full Text] [Related]
10. The efficacy of drug treatments for dysthymia: a systematic review and meta-analysis.
de Lima MS; Hotoph M; Wessely S
Psychol Med; 1999 Nov; 29(6):1273-89. PubMed ID: 10616934
[TBL] [Abstract][Full Text] [Related]
11. The undertreatment of dysthymia.
Shelton RC; Davidson J; Yonkers KA; Koran L; Thase ME; Pearlstein T; Halbreich U
J Clin Psychiatry; 1997 Feb; 58(2):59-65. PubMed ID: 9062374
[TBL] [Abstract][Full Text] [Related]
12. Treatment of double depression: A meta-analysis.
May DG; Shaffer VN; Yoon KL
Psychiatry Res; 2020 Sep; 291():113262. PubMed ID: 32763535
[TBL] [Abstract][Full Text] [Related]
13. Does the chronological relationship between the onset of dysthymia and major depression influence subsequent response to antidepressants?
Levitt AJ; Joffe RT; Sokolov ST
J Affect Disord; 1998 Jan; 47(1-3):169-75. PubMed ID: 9476757
[TBL] [Abstract][Full Text] [Related]
14. A pharmacotherapy algorithm for the treatment of dysthymia in Japan.
Kitamura H; Yokoyama T; Someya T
Psychiatry Clin Neurosci; 1999 Oct; 53 Suppl():S49-53. PubMed ID: 10560899
[TBL] [Abstract][Full Text] [Related]
15. [Dysthymic disorders].
Ferreri M; Morand P; Elatki S; Nuss P
Rev Prat; 1999 Apr; 49(7):717-22. PubMed ID: 10337215
[TBL] [Abstract][Full Text] [Related]
16. A randomized controlled trial of duloxetine versus placebo in the treatment of nonmajor chronic depression.
Hellerstein DJ; Stewart JW; McGrath PJ; Deliyannides DA; Batchelder ST; Black SR; Withers A; O'Shea D; Chen Y
J Clin Psychiatry; 2012 Jul; 73(7):984-91. PubMed ID: 22901348
[TBL] [Abstract][Full Text] [Related]
17. Geriatric dysthymia.
Kocsis JH
J Clin Psychiatry; 1998; 59 Suppl 10():13-5. PubMed ID: 9720477
[TBL] [Abstract][Full Text] [Related]
18. Dysthymic disorder in the elderly population.
Devanand DP
Int Psychogeriatr; 2014 Jan; 26(1):39-48. PubMed ID: 24152873
[TBL] [Abstract][Full Text] [Related]
19. Current pharmacotherapeutic approaches for dysthymic disorder and persistent depressive disorder.
Carta MG; Paribello P; Nardi AE; Preti A
Expert Opin Pharmacother; 2019 Oct; 20(14):1743-1754. PubMed ID: 31290333
[No Abstract] [Full Text] [Related]
20. Dopaminergic deficit and the role of amisulpride in the treatment of mood disorders.
Montgomery SA
Int Clin Psychopharmacol; 2002 Dec; 17 Suppl 4():S9-15; discussion S16-7. PubMed ID: 12685917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
